Dolby Laboratories (DLB) Insider Kevin J. Yeaman Sells 17,590 Shares of Stock

Dolby Laboratories (NYSE:DLB) insider Kevin J. Yeaman sold 17,590 shares of the business’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $62.45, for a total value of $1,098,495.50. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Kevin J. Yeaman also recently made the following trade(s):

  • On Monday, December 18th, Kevin J. Yeaman sold 11,130 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.47, for a total value of $695,291.10.
  • On Thursday, November 2nd, Kevin J. Yeaman sold 10,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $58.38, for a total value of $583,800.00.

Dolby Laboratories (NYSE DLB) traded down $0.16 on Wednesday, reaching $62.44. The company had a trading volume of 207,100 shares, compared to its average volume of 380,231. Dolby Laboratories has a 12-month low of $44.98 and a 12-month high of $63.34. The firm has a market capitalization of $6,403.23, a PE ratio of 30.10, a PEG ratio of 2.32 and a beta of 0.86.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Wednesday, October 25th. The electronics maker reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.18. Dolby Laboratories had a return on equity of 10.62% and a net margin of 18.66%. The firm had revenue of $242.05 million for the quarter, compared to analysts’ expectations of $244.80 million. During the same period in the prior year, the firm posted $0.37 earnings per share. The firm’s quarterly revenue was up 3.9% on a year-over-year basis. equities research analysts expect that Dolby Laboratories will post 2.24 EPS for the current year.

Several brokerages have recently weighed in on DLB. Zacks Investment Research cut Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 31st. B. Riley reiterated a “buy” rating and issued a $65.50 price objective on shares of Dolby Laboratories in a report on Thursday, October 26th. Dougherty & Co reiterated a “buy” rating and issued a $63.00 price objective on shares of Dolby Laboratories in a report on Wednesday, September 13th. Piper Jaffray Companies reiterated a “hold” rating and issued a $52.00 price objective (up from $49.00) on shares of Dolby Laboratories in a report on Wednesday, September 13th. Finally, BidaskClub cut Dolby Laboratories from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $60.17.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in Dolby Laboratories by 2.2% in the second quarter. Vanguard Group Inc. now owns 4,725,496 shares of the electronics maker’s stock valued at $231,360,000 after purchasing an additional 103,702 shares during the period. BlackRock Inc. raised its position in Dolby Laboratories by 19.8% in the second quarter. BlackRock Inc. now owns 2,913,371 shares of the electronics maker’s stock valued at $142,639,000 after purchasing an additional 481,649 shares during the period. Janus Henderson Group PLC raised its position in Dolby Laboratories by 352.2% in the third quarter. Janus Henderson Group PLC now owns 2,657,618 shares of the electronics maker’s stock valued at $152,875,000 after purchasing an additional 2,069,849 shares during the period. American Century Companies Inc. raised its position in Dolby Laboratories by 0.9% in the third quarter. American Century Companies Inc. now owns 1,844,837 shares of the electronics maker’s stock valued at $106,115,000 after purchasing an additional 16,420 shares during the period. Finally, TimesSquare Capital Management LLC raised its position in Dolby Laboratories by 6.9% in the third quarter. TimesSquare Capital Management LLC now owns 1,795,000 shares of the electronics maker’s stock valued at $103,248,000 after purchasing an additional 116,500 shares during the period. Hedge funds and other institutional investors own 52.53% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Dolby Laboratories (DLB) Insider Kevin J. Yeaman Sells 17,590 Shares of Stock” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://sportsperspectives.com/2017/12/20/dolby-laboratories-dlb-insider-kevin-j-yeaman-sells-17590-shares-of-stock.html.

About Dolby Laboratories

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply